Elizabeth Gardiner, TB Alliance Introducing New Tools & Approaches (INAT) - Berlin November 12, 2010.

Slides:

Advertisements

Similar presentations

WCDR Thematic Panel Governance: Institutional and Policy Frameworks for Risk Reduction Annotated Outline UNDP – UNV – ProVention Consortium – UN-Habitat.

Advertisements

The role of the Early Recovery Advisor DOCO Strategic Planning Training Workshop, November 2008, New York.

The Global Laboratory Initiative Assisting countries to implement the WHA resolution on MDR-TB Karin Weyer, WHO-STB, GLI secretariat John Ridderhof, CDC,

Pharmaceuticals and Global Health Inequalities and Innovation in the 21 st Century.

Retooling Task Force. Liquid Media for Culture and Drug Susceptibility Testing Generic checklist for TB Diagnostics developed by Retooling Task Force.

TBD-UK: The UK response in the discovery and development of new TB drugs. Dr Geoff Coxon Deputy Leader & Director of Medicinal Chemistry, TBD-UK APPG-TB.

Focus on Vaccines: Priorities and Responses to Cape Town Recommendations Retooling Task Force Meeting January 15, 2008.

Knows and performs Illinois Professional Teaching Standards including working with diverse learners Demonstrates basic competency in planning, instruction,

Working Group on New Vaccines. Purpose of the Working Group on New Vaccines Facilitate the development of new, more effective TB vaccine by promoting.

3rd WHO Prequalification Stakeholders Meeting

COMPANION GRAPHS. Annual Global Plan Research Funding Targets vs Investments $800,000,000 $600,000,000 $400,000,000 $200,000,000 $0 Fundamental.

CFCS grant recipient: AFRO Global Alliance (AGA), Ghana Project: TB Voice Network Advocacy, Communication and Social Mobilization (ACSM) Subgroup Meeting.

Collaboration and Learning The perspective of a Cluster.

Communities of Practice in NHS Scotland Annette Thain

How to Foster and Measure Social Inclusion NatStats08 20 November 2008 Melbourne Professor Fiona Stanley AC Director Telethon Institute for Child Health.

EoI assesment and presentation NCP 24 October 2002 Confronting the major communicable diseases linked to poverty Health Directorate F3 unit: Poverty related.

Introducing Global Health Trials - your online specialist professional network Liam Boggs The Global Health Network University of Oxford Centre for Clinical.

ICARE Member Reports ETP seeks to improve incentives and encourage commercial investment in new therapies. (Treatments reach patients only by commercial.

Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.

22 March 2012 Europe and ACP together against tuberculosis European Parliament, Rue Wiertz 60 BRUSSELS Charles S Mgone EDCTP Executive Director.

EVOLVING PUBLIC HEALTH AND HEALTH CARE LANDSCAPE AND OPPORTUNITIES FOR CANCER COMMUNICATION NCI Health Communication and Informatics Research Branch CPCRN.

PUTTING AN END TO TB WHERE ARE THE OPPORTUNITIES AND WHAT ARE THE CHALLENGES? STRATEGY MEETING ON RESOURCE MOBILIZATION FOR THE GLOBAL FUND TO FIGHT AIDS,

Zimbabwe National HIV&AIDS Conference, Harare, 5-8 Sept 2011

1 Using information, dialogue & advocacy platforms to facilitate civil society responses to AIDS & TB Presentation to the Stop TB Partnership November.

Global Campaign for Microbicides Rebekah Webb, European Coordinator

London’s leading voice for volunteering Volunteering in London Informing and advocating for 2012 Building the volunteering legacy for London’s communities.

CPTR Key Accomplishments: Research Resources Group October 3, 2012.

Diagnostic Detectives Toolkit Dr. Robert Martin Director, Division of Public Health Partnerships National Center for Health Marketing Centers for Disease.

WHO Expert Working Group on R&D Financing Stop TB New Tools Working Groups Marcos Espinal Executive Secretary.

Have your say! 10 September Introductions  Nick Davies Public Services Manger, NCVO  Angie Macknight VCSE Review Manager.

The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.

CHAIR: Mr. R.A. Khan, RAPPORTEUR: Dr. K.D. Singh Group: 3.

Johannesburg, 13 th August 2009 Outstanding Business Action to Stop TB: How Companies Contribute to the Global Fight 2009 TB Case Studies Shuma Panse Global.

2nd Meeting of the Subgroup on Advocacy, Communications and Social Mobilization at Country Level Program Review Guide Purpose: Plan: Revision:

Pharmabridge, FIP New Orleans FIP-Pharmabridge status report Agathe Wehrli Introduction Website and database Links established Unlinked needs and.

Update of the Global Plan to Stop TB TB/HIV Working Group Meeting Geneva, November 2009 Christian Lienhardt.

So You Want to Change the World Forum - Trauma-Informed Care & Practice 7 May 2015 Corinne Henderson Senior Policy Advisor Mental Health Coordinating Council.

School of SOCIAL AND COMMUNITY MEDICINE University of BRISTOL Shall we meet for coffee? Experiments in ways of bridging the researcher commissioner gap:

INAT and Research Christian Lienhardt Stop TB Partnership Geneva First Meeting of the Core Group of the Subgroup on Introducing New Tools and Approaches.

The European Innovation Partnership for asthma: an opportunity for change Samantha Walker PhD, Asthma UK Project Coordinator, EARIP (European Asthma Research.

Increasing Momentum in the Formation of State and Regional Monitoring Councils Linda Green, co-chair, Collaboration and Outreach Workgroup, National Water.

TB Public Private Partnerships Opportunity or Risk? Cheri Vincent Senior Public Health Advisor USAID June 3, 2008.

DEWG Meeting Geneva 14 October 2009 TB in children Report from the breakout session.

 Civil Society is understood to encompass all associations formal and informal that are outside the state and the private market sector. They are associations,

Resource Mobilization and Awareness Working Group Mercedes Mas de Xaxás Population Action International.

Digital Media. INTERACTIVE MEDIA: WEB 2.0 AND YOU Internet Basics The Internet Audience Internet Marketing The Internet as a Marcom Medium The Roles of.

Community involvement in scaling up TB/HIV activities.

Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004.

The Stop TB Partnership Task Force on “Retooling” Update for the Working Groups Annual Meeting Vinand Nantulya & Nina Schwalbe, co-chairs of Task Force.

GEO Working Group On Land Cover For Africa (WGLCA – Update) Ms Semoli Bulelwa - WGLCA Dr Amadou M. Dieye - TAG GEO WGLCA GEO Plenary XII, Mexico City,

Vaccine Enterprise & Collaboration Bill Snow, Director 19 January 2013 CHVI Afri-Can Forum.

Social Marketing Toolkit Helen Young ALC Manager June 2009

WG report backs: New TB Vaccines & TB/HIV INAT Meeting November 12, 2010 Berlin.

Presentation to CSA November 24 th, 2015 Meredith Kushnir, Marketing and Community Engagement Coordinator, CICMH.

The path to efficacy Pearson’s approach to improving learner outcomes [Presenter’s name, ]

Summary of potential priority actions for CMWG Case Management Working Group Meeting 8-9 July 2009.

Medical Writing Special Interest Area Community (SIAC) Medical Communications March Workshop 2012 David Clemow SIAC Chair Melissa Ossanna Communications.

State of the TB Alliance

Come and be a member of our website.

Putting the Evidence into Practice

Accessing Medicines in Africa Prospects and challenges

World Health Organization

World Health Organization

ACSM in 2010: Overview of SG Achievements

The UNIDO Department of Policy, Research and Statistics

Action Points 6 November 2007 Cape Town, South Africa

Promoting Adoption and Implementation of WHO recommendations

Topic Pack: Help with Prescription Drugs

Topic Pack: Locating Providers and Preparing for Visits

Presentation transcript:

Elizabeth Gardiner, TB Alliance Introducing New Tools & Approaches (INAT) - Berlin November 12, 2010

New Drug Working Group Co-Chairs: Mel Spigelman & Bill Bishai Members: 140+ including pharmaceutical companies, TB Alliance, TAG, Community Representative (Zimbabwe), BMGF Subgroups on Clinical Trial Capacity, Biology Targets, New Candidates, Knowledge & Tools Focus: R&D information sharing Website with pipeline, blog, videos Future: introduction of new drugs

Linkage with INAT For WGND Information about INAT Link to INAT website, slides about what INAT is Guidance Who/where is the TB drug market What patients/countries want How can products be used What dose works for uptake Help Community Representative deliver the right message to the audience For INAT Useful pipeline for INAT Go-to for scientific information on new drugs Other?

MDR Working Group Chair: Ahmer Khan, Indus Hospital Members: PIH, WHO/SEARO, WHO/GVA, Community Representatives (Nigeria & India), Union, BMGF, Resist-TB, USAID, Eli Lily, PATH Subgroups on Research, Infection Control & Prevention, Drug Management, Diagnostics Overseeing & providing guidance on MDR issues including subgroup topics, GLI, compassionate use, etc.

Role for INAT Should be grounded in framework of RTF Need for coordination more than encouragement Wants INAT to track/disseminate info on all related new tools activities across Partnership, Department, & TDR, donor-funded activities (e.g. STREAM study, LPA studies, GenExpert availability) identify sources of information on X, Y & Z (e.g. diagnostics, Resist-TB, TMC 207) Advocate for new tools but through existing structures